Vinay Subhash Mahajan, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immunologic Tests | 2 | 2019 | 103 | 1.330 |
Why?
|
N-Acetylneuraminic Acid | 2 | 2019 | 181 | 1.140 |
Why?
|
B-Lymphocytes | 8 | 2021 | 4665 | 0.980 |
Why?
|
Immunoglobulin G | 15 | 2019 | 4561 | 0.910 |
Why?
|
Autoimmune Diseases | 9 | 2016 | 2134 | 0.810 |
Why?
|
Immune System Diseases | 3 | 2019 | 261 | 0.800 |
Why?
|
GTPase-Activating Proteins | 2 | 2019 | 498 | 0.660 |
Why?
|
Guanine Nucleotide Exchange Factors | 2 | 2019 | 581 | 0.640 |
Why?
|
CpG Islands | 1 | 2021 | 1170 | 0.570 |
Why?
|
Genetic Techniques | 1 | 2019 | 435 | 0.560 |
Why?
|
Plasma Cells | 6 | 2018 | 593 | 0.550 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 602 | 0.490 |
Why?
|
Lectins | 1 | 2016 | 513 | 0.450 |
Why?
|
T-Lymphocytes, Cytotoxic | 6 | 2022 | 1821 | 0.440 |
Why?
|
CD4-Positive T-Lymphocytes | 9 | 2022 | 4386 | 0.440 |
Why?
|
CD8-Positive T-Lymphocytes | 6 | 2022 | 4477 | 0.440 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2016 | 548 | 0.430 |
Why?
|
Gene Targeting | 1 | 2016 | 879 | 0.430 |
Why?
|
Receptors, Antigen, T-Cell | 3 | 2019 | 2540 | 0.420 |
Why?
|
Influenza, Human | 2 | 2022 | 1480 | 0.400 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2019 | 3591 | 0.360 |
Why?
|
Erythrocytes | 1 | 2019 | 2455 | 0.340 |
Why?
|
Th2 Cells | 3 | 2020 | 1061 | 0.320 |
Why?
|
Troponin | 1 | 2011 | 524 | 0.310 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 1937 | 0.300 |
Why?
|
Immunologic Memory | 4 | 2016 | 1347 | 0.260 |
Why?
|
HIV Seropositivity | 1 | 2010 | 971 | 0.250 |
Why?
|
AIDS Vaccines | 1 | 2010 | 938 | 0.230 |
Why?
|
RNA, Viral | 2 | 2010 | 2901 | 0.230 |
Why?
|
HIV Antibodies | 1 | 2010 | 1322 | 0.230 |
Why?
|
Virus Diseases | 1 | 2008 | 711 | 0.210 |
Why?
|
B-Lymphocyte Subsets | 1 | 2023 | 246 | 0.200 |
Why?
|
Fibrosis | 6 | 2023 | 2030 | 0.200 |
Why?
|
Disinfectants | 1 | 2022 | 116 | 0.190 |
Why?
|
Human Genome Project | 1 | 2001 | 193 | 0.190 |
Why?
|
Mediastinitis | 1 | 2020 | 48 | 0.190 |
Why?
|
Histoplasma | 1 | 2020 | 41 | 0.190 |
Why?
|
Hypersensitivity, Immediate | 2 | 2013 | 337 | 0.190 |
Why?
|
Histoplasmosis | 1 | 2020 | 66 | 0.190 |
Why?
|
Sclerosis | 1 | 2020 | 213 | 0.180 |
Why?
|
Haptoglobins | 1 | 2021 | 165 | 0.180 |
Why?
|
Receptors, Interleukin-7 | 2 | 2011 | 38 | 0.180 |
Why?
|
Hemagglutinins, Viral | 1 | 2019 | 67 | 0.170 |
Why?
|
Viral Fusion Proteins | 1 | 2019 | 96 | 0.170 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2022 | 459 | 0.160 |
Why?
|
Acute Coronary Syndrome | 1 | 2011 | 2337 | 0.160 |
Why?
|
Germinal Center | 1 | 2020 | 377 | 0.150 |
Why?
|
Mice, Knockout | 5 | 2021 | 14563 | 0.150 |
Why?
|
T-Lymphocytes, Helper-Inducer | 2 | 2020 | 985 | 0.150 |
Why?
|
Erythroid Cells | 1 | 2019 | 239 | 0.150 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2021 | 794 | 0.150 |
Why?
|
Protein Precursors | 1 | 2021 | 1154 | 0.150 |
Why?
|
Immunophenotyping | 2 | 2019 | 1880 | 0.140 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2017 | 98 | 0.140 |
Why?
|
Galectin 3 | 1 | 2018 | 228 | 0.140 |
Why?
|
Scleroderma, Systemic | 1 | 2020 | 323 | 0.140 |
Why?
|
Autoantigens | 2 | 2018 | 892 | 0.140 |
Why?
|
Sialadenitis | 1 | 2016 | 43 | 0.140 |
Why?
|
Inflammation | 3 | 2023 | 10629 | 0.140 |
Why?
|
Acetylation | 1 | 2019 | 1084 | 0.140 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2021 | 612 | 0.140 |
Why?
|
Dacryocystitis | 1 | 2016 | 70 | 0.130 |
Why?
|
Chromosomes, Mammalian | 1 | 2016 | 151 | 0.130 |
Why?
|
Homeostasis | 2 | 2011 | 3337 | 0.130 |
Why?
|
Mice | 10 | 2021 | 81154 | 0.130 |
Why?
|
Gene Duplication | 1 | 2016 | 328 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2022 | 971 | 0.130 |
Why?
|
Crosses, Genetic | 1 | 2016 | 791 | 0.130 |
Why?
|
Chromosome Segregation | 1 | 2016 | 235 | 0.130 |
Why?
|
Immunoglobulin E | 3 | 2018 | 1463 | 0.120 |
Why?
|
Granuloma, Lethal Midline | 1 | 2014 | 4 | 0.120 |
Why?
|
Flow Cytometry | 4 | 2019 | 5973 | 0.120 |
Why?
|
Animals | 14 | 2021 | 168660 | 0.120 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 3874 | 0.120 |
Why?
|
Antibody-Producing Cells | 1 | 2014 | 143 | 0.120 |
Why?
|
Myeloid Cells | 1 | 2019 | 808 | 0.120 |
Why?
|
Inheritance Patterns | 1 | 2016 | 339 | 0.120 |
Why?
|
Eosinophils | 2 | 2016 | 954 | 0.120 |
Why?
|
Apoptosis | 2 | 2020 | 9718 | 0.120 |
Why?
|
Hypergammaglobulinemia | 1 | 2013 | 74 | 0.120 |
Why?
|
Humans | 38 | 2023 | 743811 | 0.110 |
Why?
|
Sensitivity and Specificity | 3 | 2021 | 14714 | 0.110 |
Why?
|
Lymphocytosis | 1 | 2014 | 119 | 0.110 |
Why?
|
Autoimmunity | 2 | 2016 | 1349 | 0.110 |
Why?
|
Cattle | 1 | 2019 | 3917 | 0.110 |
Why?
|
Immunity, Humoral | 1 | 2017 | 598 | 0.110 |
Why?
|
HIV-1 | 1 | 2010 | 6939 | 0.110 |
Why?
|
Mice, Inbred C57BL | 5 | 2019 | 21824 | 0.110 |
Why?
|
Myofibroblasts | 1 | 2014 | 222 | 0.110 |
Why?
|
MicroRNAs | 1 | 2008 | 3750 | 0.110 |
Why?
|
Pancreas | 1 | 2019 | 1686 | 0.110 |
Why?
|
Epitopes | 1 | 2019 | 2570 | 0.100 |
Why?
|
Immunologic Factors | 3 | 2017 | 1580 | 0.100 |
Why?
|
Cathepsins | 2 | 2003 | 238 | 0.100 |
Why?
|
Antibodies, Neutralizing | 1 | 2021 | 1978 | 0.100 |
Why?
|
Antigens, CD | 2 | 2020 | 4026 | 0.100 |
Why?
|
Serologic Tests | 1 | 2013 | 375 | 0.100 |
Why?
|
Point-of-Care Systems | 1 | 2019 | 1177 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2021 | 3175 | 0.090 |
Why?
|
Intestinal Mucosa | 1 | 2021 | 3038 | 0.090 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2419 | 0.090 |
Why?
|
Exons | 1 | 2016 | 2438 | 0.090 |
Why?
|
Interferon-gamma | 2 | 2016 | 3205 | 0.090 |
Why?
|
Genetic Markers | 1 | 2016 | 2634 | 0.090 |
Why?
|
Mesenchymal Stem Cells | 1 | 2020 | 1632 | 0.090 |
Why?
|
Autoantibodies | 2 | 2018 | 2037 | 0.090 |
Why?
|
Eosinophilia | 1 | 2013 | 541 | 0.080 |
Why?
|
Mice, Transgenic | 2 | 2019 | 9731 | 0.080 |
Why?
|
Fibroblasts | 1 | 2019 | 4162 | 0.080 |
Why?
|
Luminescent Measurements | 1 | 2010 | 405 | 0.080 |
Why?
|
Lymphocyte Count | 3 | 2016 | 793 | 0.080 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1608 | 0.080 |
Why?
|
False Positive Reactions | 1 | 2010 | 980 | 0.080 |
Why?
|
Gene Expression | 1 | 2021 | 7793 | 0.080 |
Why?
|
Cell Differentiation | 2 | 2021 | 11478 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2020 | 3482 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2005 | 10179 | 0.070 |
Why?
|
DNA Methylation | 1 | 2021 | 4286 | 0.070 |
Why?
|
RNA, Messenger | 3 | 2016 | 13028 | 0.070 |
Why?
|
Immunoassay | 1 | 2010 | 751 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2016 | 2258 | 0.070 |
Why?
|
Genetic Loci | 1 | 2016 | 2575 | 0.070 |
Why?
|
Submandibular Gland | 2 | 2016 | 86 | 0.070 |
Why?
|
Male | 20 | 2021 | 349776 | 0.070 |
Why?
|
Base Sequence | 2 | 2016 | 12798 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2019 | 9440 | 0.070 |
Why?
|
Lymphocyte Activation | 4 | 2020 | 5524 | 0.070 |
Why?
|
Antigens | 1 | 2010 | 1466 | 0.060 |
Why?
|
Alleles | 1 | 2016 | 6934 | 0.060 |
Why?
|
Pandemics | 2 | 2021 | 8385 | 0.060 |
Why?
|
Middle Aged | 16 | 2020 | 213241 | 0.060 |
Why?
|
Immunoglobulin D | 1 | 2023 | 56 | 0.060 |
Why?
|
Female | 19 | 2021 | 380020 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2016 | 15518 | 0.060 |
Why?
|
Receptors, CXCR5 | 1 | 2023 | 92 | 0.060 |
Why?
|
Rubber | 1 | 2022 | 50 | 0.050 |
Why?
|
Antigens, Viral | 2 | 2021 | 1035 | 0.050 |
Why?
|
Nylons | 1 | 2022 | 47 | 0.050 |
Why?
|
Blotting, Western | 1 | 2010 | 5179 | 0.050 |
Why?
|
Acrylates | 1 | 2022 | 89 | 0.050 |
Why?
|
Rats | 1 | 2019 | 24250 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3134 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.050 |
Why?
|
Gene Silencing | 1 | 2008 | 1537 | 0.050 |
Why?
|
Adult | 15 | 2020 | 213889 | 0.050 |
Why?
|
Leukocyte Count | 2 | 2016 | 1588 | 0.050 |
Why?
|
T-Lymphocyte Subsets | 2 | 2022 | 1837 | 0.050 |
Why?
|
Oligopeptides | 2 | 2021 | 1188 | 0.050 |
Why?
|
Phenotype | 2 | 2016 | 16361 | 0.050 |
Why?
|
Spleen | 2 | 2020 | 2359 | 0.050 |
Why?
|
Polyethylenes | 1 | 2022 | 285 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 193 | 0.040 |
Why?
|
Fungi | 1 | 2022 | 326 | 0.040 |
Why?
|
Dendritic Cells | 1 | 2010 | 2720 | 0.040 |
Why?
|
Aged, 80 and over | 7 | 2020 | 57744 | 0.040 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2006 | 1366 | 0.040 |
Why?
|
Ribonucleotides | 1 | 2019 | 117 | 0.040 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2019 | 88 | 0.040 |
Why?
|
Permeability | 1 | 2021 | 738 | 0.040 |
Why?
|
5'-Nucleotidase | 1 | 2019 | 160 | 0.040 |
Why?
|
Immunosorbent Techniques | 1 | 2018 | 184 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2020 | 645 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2019 | 435 | 0.040 |
Why?
|
Electrocardiography | 1 | 2011 | 6441 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2020 | 19232 | 0.040 |
Why?
|
Glucocorticoids | 2 | 2017 | 2107 | 0.040 |
Why?
|
Aged | 10 | 2020 | 163178 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2020 | 4422 | 0.040 |
Why?
|
Chemokine CCL4 | 1 | 2016 | 129 | 0.040 |
Why?
|
Signal Transduction | 2 | 2011 | 23398 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2019 | 610 | 0.030 |
Why?
|
Perforin | 1 | 2016 | 168 | 0.030 |
Why?
|
Chemokine CCL5 | 1 | 2016 | 209 | 0.030 |
Why?
|
Retroperitoneal Space | 1 | 2016 | 176 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 21733 | 0.030 |
Why?
|
Young Adult | 6 | 2021 | 56392 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1342 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 2017 | 608 | 0.030 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 890 | 0.030 |
Why?
|
Peptides | 2 | 2005 | 4406 | 0.030 |
Why?
|
Granzymes | 1 | 2016 | 271 | 0.030 |
Why?
|
Nasal Septum | 1 | 2016 | 127 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2018 | 881 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2018 | 10477 | 0.030 |
Why?
|
Sjogren's Syndrome | 1 | 2016 | 234 | 0.030 |
Why?
|
Antibody Diversity | 1 | 2014 | 74 | 0.030 |
Why?
|
Time Factors | 2 | 2016 | 40038 | 0.030 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2014 | 97 | 0.030 |
Why?
|
Biopsy | 2 | 2017 | 6750 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2016 | 471 | 0.030 |
Why?
|
Recurrence | 2 | 2016 | 8337 | 0.030 |
Why?
|
Cathepsin L | 2 | 2003 | 74 | 0.030 |
Why?
|
Placenta | 1 | 2002 | 1699 | 0.030 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2016 | 644 | 0.030 |
Why?
|
Promoter Regions, Genetic | 1 | 2003 | 5867 | 0.030 |
Why?
|
Lymph Nodes | 2 | 2016 | 3476 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2503 | 0.030 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 2014 | 482 | 0.030 |
Why?
|
Mutation | 1 | 2016 | 29777 | 0.020 |
Why?
|
Bacteria | 1 | 2022 | 2112 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2014 | 693 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2203 | 0.020 |
Why?
|
Collagen | 1 | 2019 | 2681 | 0.020 |
Why?
|
Lung | 2 | 2022 | 9858 | 0.020 |
Why?
|
Clone Cells | 1 | 2014 | 1692 | 0.020 |
Why?
|
Interleukin-7 | 1 | 2011 | 142 | 0.020 |
Why?
|
Remission Induction | 1 | 2016 | 2384 | 0.020 |
Why?
|
Cysteine Endopeptidases | 2 | 2003 | 563 | 0.020 |
Why?
|
Orthomyxoviridae | 1 | 2010 | 156 | 0.020 |
Why?
|
Cytokines | 2 | 2016 | 7324 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6620 | 0.020 |
Why?
|
Genome, Human | 1 | 2001 | 4418 | 0.020 |
Why?
|
Orthomyxoviridae Infections | 1 | 2010 | 247 | 0.020 |
Why?
|
Adoptive Transfer | 1 | 2010 | 844 | 0.020 |
Why?
|
Disease Progression | 2 | 2014 | 13273 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2727 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11360 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 40545 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2008 | 479 | 0.020 |
Why?
|
Gene Expression Regulation | 3 | 2011 | 12066 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6539 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7172 | 0.010 |
Why?
|
TATA Box | 1 | 2003 | 128 | 0.010 |
Why?
|
Genetic Variation | 1 | 2019 | 6535 | 0.010 |
Why?
|
Models, Immunological | 1 | 2006 | 527 | 0.010 |
Why?
|
Transcription Initiation Site | 1 | 2003 | 196 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2010 | 2509 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 85729 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2003 | 676 | 0.010 |
Why?
|
Luciferases | 1 | 2003 | 733 | 0.010 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2006 | 1475 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12354 | 0.010 |
Why?
|
Blotting, Southern | 1 | 2002 | 803 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2021 | 25609 | 0.010 |
Why?
|
Introns | 1 | 2003 | 991 | 0.010 |
Why?
|
Ligands | 1 | 2008 | 3281 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3847 | 0.010 |
Why?
|
Cell Survival | 1 | 2011 | 5881 | 0.010 |
Why?
|
Cell Line | 2 | 2006 | 15993 | 0.010 |
Why?
|
Kidney | 1 | 2016 | 7185 | 0.010 |
Why?
|
Leucine | 1 | 2002 | 559 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35122 | 0.010 |
Why?
|
Pregnancy Trimester, Third | 1 | 2002 | 571 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2003 | 1524 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12944 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2016 | 63042 | 0.010 |
Why?
|
Isoenzymes | 1 | 2003 | 1728 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 40964 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18355 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18027 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2003 | 1117 | 0.010 |
Why?
|
Pregnancy Trimester, First | 1 | 2002 | 853 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2016 | 77410 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15211 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 5892 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3772 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 6111 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 9582 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 4749 | 0.010 |
Why?
|
Child | 1 | 2021 | 77637 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39001 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 18107 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 7719 | 0.010 |
Why?
|
Risk Factors | 1 | 2016 | 72252 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2003 | 16674 | 0.000 |
Why?
|
Pregnancy | 1 | 2002 | 29140 | 0.000 |
Why?
|